About 216,000 results
Open links in new tab
  1. Geron Corp (GERN) Stock Price & News - Google Finance

    Get the latest Geron Corp (GERN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  2. Geron Corporation (GERN) - Yahoo Finance

    Find the latest Geron Corporation (GERN) stock quote, history, news and other vital information to help you with your stock trading and investing.

  3. Geron Corporation Common Stock (GERN) - Nasdaq

    Oct 25, 2025 · Discover real-time Geron Corporation Common Stock (GERN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions.

  4. GERN Stock Price | Geron Corp. Stock Quote (U.S.: Nasdaq) | MarketWatch

    Dec 26, 2025 · GERN | Complete Geron Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

  5. GERN: Geron Corp - Stock Price, Quote and News - CNBC

    Get Geron Corp (GERN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

  6. Geron (GERN) Stock Price & Overview

    2 days ago · A detailed overview of Geron Corporation (GERN) stock, including real-time price, chart, key statistics, news, and more.

  7. Geron Corporation (GERN) Stock Price, Quote, News & Analysis

    A high-level overview of Geron Corporation (GERN) stock. View (GERN) real-time stock price, chart, news, analysis, analyst reviews and more.

  8. GERN Stock Price Quote | Morningstar

    5 days ago · See the latest Geron Corp stock price (GERN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

  9. Geron Corporation - Investors & Media

    Dec 11, 2025 · Geron is a commercial-stage biopharmaceutical company with a first-in-class telomerase inhibitor that is approved in the United States for the treatment of certain adult …

  10. Geron (GERN) Stock Price, News & Analysis - MarketBeat

    3 days ago · Geron Corporation (NASDAQ: GERN) is a clinical-stage biotechnology company dedicated to developing and commercializing novel treatments that target telomerase, an …